What a Nurse Told Me About Mushrooms - and Why the VA Just Proved Her Right

I had a conversation a few weeks back that stuck with me. A nurse named Dawn - someone who trained medics on how to deal with trauma and PTSD in the field - told me about psilocybin. The active compound in what people call "magic mushrooms." And the research that was quietly building momentum behind it.

I'll be honest - I was skeptical. I've heard enough "miracle cure" stories to last a lifetime. But Dawn wasn't selling anything. She was a medical professional who'd seen the research, who'd worked with people carrying the kind of weight that doesn't show up on an x-ray. And she was frustrated that more people didn't know about it.

So I started looking into it myself. And what I found surprised me.

On August 5, 2026, the Department of Veterans Affairs launched a clinical trial called PIVOT - Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression.

This isn't some fringe study. It's a randomized, controlled trial at five VA medical centers across the country - Birmingham, Tuscaloosa, Portland, Philadelphia, and Seattle. They're enrolling veterans with treatment-resistant major depressive disorder, including those with concurrent PTSD.

And it's not the only one. The VA currently has 20 active clinical trials focused on psychedelic therapies for mental health conditions.

While the VA trial is just getting started, a study published on July 30, 2026, in the journal Communications Medicine showed something that's hard to ignore.

Ohio State University ran the first U.S. clinical trial of psilocybin-assisted therapy specifically for veterans with severe, treatment-resistant PTSD. These were people who had tried everything else and nothing worked.

The results: 75% of participants - 9 out of 12 veterans - were in remission one month after treatment. Their symptoms no longer met the criteria for PTSD.

No serious adverse events. No increase in suicidal thinking. The most common side effect was a mild headache.

One of the participants, Zachariah Collett, an Army veteran who served a 28-month combat tour in Iraq, said: "It allowed me the opportunity to create peace, and stillness, and acceptance, and forgiveness and grace - all those things opposite of resentment and anger and hatred."

Three years after his treatment, he says the effects held.

This isn't about taking mushrooms at a party. The protocol combines intensive psychotherapy with carefully dosed, pharmaceutical-grade psilocybin in a controlled clinical setting. The drug acts as a catalyst - it opens a window that lets the therapy go deeper than it normally could.

As Dr. Alan Davis, the study's senior author, put it: "The drug itself is a catalyst for the deep work. That's where the magic actually happens - in the therapy, and in the changes that people start to make in their lives after the treatment's concluded."

The FDA has granted breakthrough therapy designation to psilocybin, MDMA, and LSD - meaning they see enough promise to fast-track the review process. COMPASS Pathways has completed two positive Phase 3 trials for psilocybin. The White House signed an executive order in April 2026 specifically to accelerate psychedelic research for serious mental illness.

This is moving. Not at the speed any of us want, but faster than I expected.

I'm not telling you to go find mushrooms. I'm not telling you to drop your current treatment. The VA itself strongly discourages self-medicating. This research is happening in controlled clinical settings with pharmaceutical-grade drugs and trained professionals.

If you're a veteran with treatment-resistant PTSD or depression, talk to your VA provider. Ask about clinical trials. The PIVOT trial is enrolling now (ClinicalTrials.gov NCT07226232 - https://clinicaltrials.gov/study/NCT07226232). There are 19 other active VA trials on psychedelic therapies.

And if you're in crisis right now, call 988 and press 1. That's the Veterans Crisis Line. It works 24/7.

Dawn knew something was coming. She'd seen the research building. She'd trained medics to deal with the fallout when the standard tools ran out. And she had the kind of quiet frustration that comes from knowing there might be a better way and watching it move too slowly.

I don't know if psilocybin is the answer. But for 9 out of 12 veterans in that Ohio State trial, it was an answer. And the VA just bet on it being worth studying at scale.

Seventeen veterans a day. That's the number that keeps me writing. If this helps even some of them, it's worth talking about.